Skip to menu Skip to content Skip to footer

2006

Conference Publication

Positive margin rates in patients with a single positive core on extended TRUS biopsy

Dangerfield, D., Samaratunga, H. and Yaxley, J. (2006). Positive margin rates in patients with a single positive core on extended TRUS biopsy. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Positive margin rates in patients with a single positive core on extended TRUS biopsy

2006

Conference Publication

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

Samaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group.

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

2006

Journal Article

A working group classification of focal prostate atrophy lesions

De Marzo A.M., Platz E.A., Epstein J.I., Ali T., Billis A., Chan T.Y., Cheng L., Datta M., Egevad L., Ertoy-Baydar D., Farree X., Fine S.W., Iczkowski K.A., Ittmann M., Knudsen B.S., Loda M., Lopez-Beltran A., Magi-Galluzzi C., Mikuz G., Montironi R., Pikarsky E., Pizov G., Rubin M.A., Samaratunga H., Sebo T., Sesterhenn I.A., Shah R.B., Signoretti S., Simko J. ... Lucia M.S. (2006). A working group classification of focal prostate atrophy lesions. American Journal of Surgical Pathology, 30 (10), 1281-1291. doi: 10.1097/01.pas.0000213289.50660.be

A working group classification of focal prostate atrophy lesions

2005

Journal Article

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms

Dong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A. and Clements, J. A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocrine-Related Cancer, 12 (4), 875-889. doi: 10.1677/erc.1.01062

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms

2005

Journal Article

Significance of stromal reaction patterns in invasive urothelial carcinoma

Samaratunga, H, Fairweather, P and Purdie, D (2005). Significance of stromal reaction patterns in invasive urothelial carcinoma. American Journal of Clinical Pathology, 123 (6), 851-857. doi: 10.1309/EE8RTB6X611G6TU

Significance of stromal reaction patterns in invasive urothelial carcinoma

2005

Journal Article

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

Landers, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F. and Gardiner, Robert A. (2005). Use of multiple biomarkers for a molecular diagnosis of prostate cancer. International Journal of Cancer, 114 (6), 950-956. doi: 10.1002/ijc.20760

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

2005

Conference Publication

Claudin 4: a new therapeutic target for prostate cancer?

Gardiner, RA, Landers, KA, Burger, MJ, Scells, B, Samaratunga, MLTH and Lavin, MF (2005). Claudin 4: a new therapeutic target for prostate cancer?. Annual Scientific Meeting of the Urological- Society-of-Australasia, Melbourne Australia, Feb 13-17, 2005. OXFORD: BLACKWELL PUBLISHING.

Claudin 4: a new therapeutic target for prostate cancer?

2005

Conference Publication

Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study

Samaratunga, H. and Brown, I. (2005). Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study. 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, San Antonio, TX, United States, 26 February - 4 March 2005. Amsterdam, Netherlands: Elsevier.

Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study

2004

Journal Article

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study

Samaratunga, H and Khoo, K (2004). Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology, 45 (1), 55-64. doi: 10.1111/j.1365-2559.2004.01895.x

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study

2004

Journal Article

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP

McCulloch, Daniel R, Akl, Pascal, Samaratunga, Hemamali, Herington, Adrian C. and Odorico, Dimitri M. (2004). Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clinical Cancer Research, 10 (1), 314-323. doi: 10.1158/1078-0432.CCR-0846-3

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP

2003

Conference Publication

Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study

Samaratunga, H and Khoo, K (2003). Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study. 92nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington D.C., Mar 22-28, 2003. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study

2002

Conference Publication

Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms (PTa) for risk of progression.

Epstein, JI, Markov, DV and Samaratunga, H (2002). Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms (PTa) for risk of progression.. 97th Annual Meeting of the American-Urological-Association, Orlando Florida, May 25-30, 2002. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms (PTa) for risk of progression.

2002

Journal Article

Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer

Burger, M. J., Tebay, M. A., Keith, P. A., Samaratunga, H. M., Clements, J. A., Lavin, M. F. and Gardiner, R. A. (2002). Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. International Journal of Cancer, 100 (2), 228-237. doi: 10.1002/ijc.10468

Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer

2002

Journal Article

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression

Samaratunga H., Makarov D.V. and Epstein J.I. (2002). Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology, 60 (2), 315-319. doi: 10.1016/S0090-4295(02)01705-3

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression

2001

Journal Article

Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection

Samaratunga, H, Weedon, D, Musgrave, N and Mccallum, N (2001). Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology, 33 (4), 532-535. doi: 10.1080/00313020120083322

Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection

2001

Journal Article

Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome

Samaratunga, Hemamali, Clarke, Belinda, Owen, Leigh, Bryson, Greg and Swanson, Cheryl (2001). Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome. Pathology International, 51 (11), 866-873. doi: 10.1046/j.1440-1827.2001.01294.x

Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome

2001

Journal Article

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas

Dong, Y, Kaushal, A, Bui, L, Chu, S, Fuller, PJ, Nicklin, J, Samaratunga, H and Clements, JA (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clinical Cancer Research, 7 (8), 2363-2371.

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas

1999

Journal Article

Cervical adenoid basal epitheliomas

Samaratunga, H (1999). Cervical adenoid basal epitheliomas. American Journal of Surgical Pathology, 23 (10), 1308-1309. doi: 10.1097/00000478-199910000-00021

Cervical adenoid basal epitheliomas

1999

Conference Publication

Upper Tract Replacement by Bladder with renal Autotransplantation and Dexon

Gardiner, R. A., Teng, H., Hardie, I. R. and Samaratunga, M.L. (1999). Upper Tract Replacement by Bladder with renal Autotransplantation and Dexon. 51st Annual Scientific meeting of the Urological Society of a, Adelaide, March 1998. Asia: Blackwell Science.

Upper Tract Replacement by Bladder with renal Autotransplantation and Dexon

1999

Conference Publication

Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia

Clements, J. A., Flanagan, J., Samaratunga, M. and Gardiner, R. A. (1999). Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia. 51st Annual Scientific meeting of the Urological Societyof Aa, Adelaide, March 1998. Asia: Blackwell Science.

Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia